Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berezin

Showing results (181-190 of 1,543) with videos related to

Pageof 155
Sort By:
La Nouvelle Presse Medicale|January 22, 1972
[Bacterial endocarditis with "associated bacteria"]E Bergogne-Berezin, N Zechovsky
Expert Review of Molecular Diagnostics|July 15, 2024
An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney diseaseAlexander E Berezin, Tetiana A Berezina, Uta C Hoppe, et al.
Biomedicines|August 29, 2024
Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart FailureTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Biomolecules|January 8, 2025
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic PeptideTetiana A Berezina, Oleksandr O Berezin, Evgen V Novikov, et al.
Cell Motility and the Cytoskeleton|July 25, 1998
Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analoguesP S Walmod, A Foley, A Berezin, et al.
Journal of Clinical Medicine|March 29, 2023
Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart FailureTetiana A Berezina, Zeljko Obradovic, Elke Boxhammer, et al.
Advances in Therapy|November 7, 2023
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart FailureTetiana A Berezina, Ivan M Fushtey, Alexander A Berezin, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart FailureAlexander A Berezin, Zeljko Obradovic, Evgen V Novikov, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by HepatokinesAlexander A Berezin, Zeljko Obradovic, Tetiana A Berezina, et al.
Neuroreport|August 31, 2011
Neural cell adhesion molecule differentially interacts with isoforms of the fibroblast growth factor receptorClaus Christensen, Vladimir Berezin, Elisabeth Bock
Pageof 155

Showing results (181-190 of 1,543) with videos related to

Sort By:
Pageof 155
La Nouvelle Presse Medicale|January 22, 1972
[Bacterial endocarditis with "associated bacteria"]E Bergogne-Berezin, N Zechovsky
Expert Review of Molecular Diagnostics|July 15, 2024
An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney diseaseAlexander E Berezin, Tetiana A Berezina, Uta C Hoppe, et al.
Biomedicines|August 29, 2024
Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart FailureTetiana A Berezina, Oleksandr O Berezin, Uta C Hoppe, et al.
Biomolecules|January 8, 2025
Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic PeptideTetiana A Berezina, Oleksandr O Berezin, Evgen V Novikov, et al.
Cell Motility and the Cytoskeleton|July 25, 1998
Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analoguesP S Walmod, A Foley, A Berezin, et al.
Journal of Clinical Medicine|March 29, 2023
Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart FailureTetiana A Berezina, Zeljko Obradovic, Elke Boxhammer, et al.
Advances in Therapy|November 7, 2023
Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart FailureTetiana A Berezina, Ivan M Fushtey, Alexander A Berezin, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart FailureAlexander A Berezin, Zeljko Obradovic, Evgen V Novikov, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by HepatokinesAlexander A Berezin, Zeljko Obradovic, Tetiana A Berezina, et al.
Neuroreport|August 31, 2011
Neural cell adhesion molecule differentially interacts with isoforms of the fibroblast growth factor receptorClaus Christensen, Vladimir Berezin, Elisabeth Bock
Pageof 155